학술논문

Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686.
Document Type
Article
Source
Neuro-Oncology; Oct2018, Vol. 20 Issue 10, p1400-1410, 11p
Subject
Language
ISSN
15228517